Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

BCRX US Equity

Biocryst Pharmaceuticals IncHealth Care · Biological Products, (No Diagnostic Substances) · CIK 882796 · FY ends Dec 31
$10.07
+0.37 (+3.81%)
USD · as of 2026-08-19 · marketstack
17 8-K filings · 0 13D · 9 13G
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by RA CAPITAL MANAGEMENT, L.P.sec.gov ↗
2026-08-0713GSchedule 13G filed — ≥5% beneficial owner (passive) · by STATE STREET CORPsec.gov ↗
2026-08-058-K 7.01Regulation FD disclosuresec.gov ↗
2026-08-058-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-08-048-K 2.05Costs associated with exit or disposal activities (restructuring) (amendment)sec.gov ↗
2026-06-298-K 7.01Regulation FD disclosuresec.gov ↗
2026-06-298-K 2.05Costs associated with exit or disposal activities (restructuring)sec.gov ↗
2026-06-128-K 5.07Submission of matters to a vote of security holderssec.gov ↗
2026-06-128-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-05-1213GSchedule 13G filed — ≥5% beneficial owner (passive) · by STATE STREET CORPsec.gov ↗
2026-05-068-K 7.01Regulation FD disclosuresec.gov ↗
2026-05-068-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-05-048-K 7.01Regulation FD disclosuresec.gov ↗
2026-04-2913GSchedule 13G filed — ≥5% beneficial owner (passive) · by VANGUARD CAPITAL MANAGEMENT LLCsec.gov ↗
2026-03-2613G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by VANGUARD GROUP INCsec.gov ↗
2026-02-268-K 7.01Regulation FD disclosuresec.gov ↗
2026-02-268-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-02-1213G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Flynn James Esec.gov ↗
2026-02-0913GSchedule 13G filed — ≥5% beneficial owner (passive) · by STATE STREET CORPsec.gov ↗
2026-01-238-K 5.02Departure/election of directors or officers; compensation (amendment)sec.gov ↗
2026-01-238-K 7.01Regulation FD disclosuresec.gov ↗
2026-01-238-K 2.03Creation of a direct financial obligationsec.gov ↗
2026-01-238-K 2.01Completion of acquisition or disposition of assetssec.gov ↗
2026-01-238-K 1.01Entry into a material definitive agreementsec.gov ↗
2026-01-128-K 8.01Other eventssec.gov ↗
2026-01-128-K 7.01Regulation FD disclosuresec.gov ↗
2026-01-128-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-01-098-K 7.01Regulation FD disclosuresec.gov ↗
2025-12-128-K 8.01Other eventssec.gov ↗
2025-12-118-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2025-12-038-K 8.01Other eventssec.gov ↗
2025-11-1313GSchedule 13G filed — ≥5% beneficial owner (passive) · by RA CAPITAL MANAGEMENT, L.P.sec.gov ↗
2025-11-038-K 7.01Regulation FD disclosuresec.gov ↗
2025-11-038-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2025-10-148-K 8.01Other eventssec.gov ↗
2025-10-148-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2025-10-148-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2025-10-148-K 1.01Entry into a material definitive agreementsec.gov ↗
2025-10-018-K 8.01Other eventssec.gov ↗
2025-10-018-K 1.01Entry into a material definitive agreementsec.gov ↗
2025-09-1913GSchedule 13G filed — ≥5% beneficial owner (passive) · by Flynn James Esec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2025-09-19

Every row is a filed document, checked against its EDGAR index.